managing editor
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
Editorial Assistant
GLENDA HARDY
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: (021) 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail :
Editorial BOARD
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published six
times a year, the deemed publication
date being the seventh day of the
second designated month,
i.e. 7 February, 7 April, 7 June, 7
August and 7 October.
Copyright:
Clinics Cardive Publishing, Pty, Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on
Pubmed
Audited circulation
Full text articles available on:
or via
co.za; for access codes contact
User ID: cvja8
Password: cvja8
Subscriptions for six issues:
South Africa: R300 (excl VAT)
Other African countries: $30
Overseas: Institutions: R845 ($82)
Individuals: R1 080 ($105)
The views and opinions expressed
in the articles and reviews published
are those of the authors and do not
necessarily reflect those of the editors
of the Journal or its sponsors. In all
clinical instances, medical practitioners
are referred to the product insert
documentation as approved by the
relevant control authorities.
CONTENTS
VOL 22, NO 5. SEPTEMBER / OCTOBER 2011
Case Reports
268 Anomalous origin of the left pulmonary artery from the ascending aorta in two children
with pulmonary atresia, sub-aortic ventricular septal defect and right-sided major
aorto-pulmonary collateral arteries
L Pepeta • FF Takawira • AM Cilliers • PE Adams • NH Ntsinjana • BJ Mitchell
272 Isolated tricuspid valve prolapse: identification using two- and three-dimensional
echocardiography and transoesophageal echocardiography
G Kocabay • D Sirma • M Mert • K Tigen
274 Double-chambered right ventricle: an uncommon congenital heart disease. Case report
and literature review
BA Animasahun • EN Ekure • OF Njokanma
Cardio News
278 South Africa’s PACE is a winner of Boehringer-Ingelheim’s international atrial fibrillation
awareness programme
Industry News
279 Medtronic news from European Society of Cardiology congress, Paris, September 2011
280 Expanded coverage for warfarin patients in the USA monitoring clotting time at home
Drug Trends
283 Namibia becomes first country in Africa to launch dabigatran etexilate for atrial
fibrillation
P Wagenaar
284 New insights and results from the RE-LY trial
287 European Society of Cardiology congress 2011
• Progress with new anticoagulants for atrial
fibrillation
• New ESC guidelines for acute coronary
syndromes (NSTEMI)
• Heart rate now a risk factor for cardiovascular
disease
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
